col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


17 Results       Page 1

 [1] 
Georg Thieme Verlag KG: Pharmacopsychiatry
  original article Date Title Authors   All Authors
1 [GO] 2025―Apr―30 The BIPCOVID Study: Investigating Shared Genetic Pathways Between COVID-19 Susceptibility and Psychiatric Symptoms in Bipolar Disorder M Mairinger, S Bengesser, N Dalkner, F Fellendorf, K Kreuzer, A Painold, et al. (+10)
2 [GO] 2025―Apr―30 Brain Fog reconsidered. Objectifying subjective cognitive impairment following COVID-19 infection. L Tarantini, C Möller, V Schiestl, S Sordon, M Noll-Hussong, M Wittemann, et al. (+2)
3 [GO] 2024―Sep―26 News on the Role of Antidepressants in and for COVID-19 and Long COVID Udo Bonnet, Georg Juckel
4 [GO] 2024―Aug―01 SARS-CoV-2-Infection in People Addicted to Illegal Drugs - Is There a Protective Effect of Opioid Maintenance Treatment? Simon Kurzhals, Martin Schäfer, Udo Bonnet, Katrin Isbruch, Stefan Kühnhold, Jörg Timm, et al. (+2)
5 [GO] 2024―Mar―26 Comparable Psychotropic Prescription Rates After Hospital Discharge Between Patients with COVID-19 and Those With Non-COVID-19-Related Respiratory Infection Yuna Takahashi, Taisuke Yatomi, Naohito Yamaguchi, Kimio Yoshimura, Satoko Hori, Hiroyuki Uchida
6 [GO] 2023―Nov―09 Prevalence of COVID-19 and Psychotropic Drug Treatment in Psychiatric In-patients in Germany in 2020: Results from a Nationwide Pilot Survey Juliane K. Mueller, Kira F. Ahrens, Michael Bauer, Bernhard T. Baune, Stefan Borgwardt, Jürgen Deckert, et al. (+27)
7 [GO] 2023―Jul―12 Revisiting the World’s Strictest COVID-19 Lockdown: Formidable Mental Health Challenges Beier Guan, Ruihua Li, Chuanning Huang, Jiang Du, Min Zhao, Shuyan Liu
8 [GO] 2022―Aug―18 Selective Serotonin Reuptake Inhibitors may Influence COVID-19 Prognosis through Antioxidant and Cytoprotective Pathways Mediated by Sigma 1 Receptor Agonism Konstantinos I. Papadopoulos, Alexandra Papadopoulou, Tar-Choon Aw
9 [GO] 2022―Jun―08 Case series: Higher antipsychotic drug levels in patients with schizophrenia after COVID-19 vaccination N. Wendler, M. Spangemacher, K. Böttcher, D. Hirjak, G. Gründer, X.M. Hart
10 [GO] 2022―Jun―02 COVID-19 Prognosis in Association with Antidepressant Use Kyung Hyun Min, Tae Hyeok Kim, Soo Jin Oh, Woorim Kim, Kyung Eun Lee
11 [GO] 2022―Jan―26 Covid-19: Contributions from Psychopharmacology Michael Bauer, Georg Juckel
12 [GO] 2022―Jan―26 Neuropsychiatric Drugs Against COVID-19: What is the Clinical Evidence? Juliane K. Mueller, Peter Riederer, Walter E. Müller
13 [GO] 2021―Nov―10 A Possible Type IV Hypersensitivity Reaction to Older Antiepileptic Drugs During and After Recovery from COVID-19 Infection Mohsen Khosravi
14 [GO] 2021―Sep―16 Impact of Psychiatric and Related Somatic Medications on the Duration and Severity of COVID-19: A Retrospective Explorative Multi-center Study from the German Metropolitan Ruhr-area Udo Bonnet, BenediktBernd Claus, Martin Schaefer, Jens Kuhn, Peter Nyhuis, Norbert Scherbaum, et al. (+3)
15 [GO] 2021―Sep―01 COVID-19: Risks, Complications, and Monitoring in Patients on Clozapine Selene R. T. Veerman, Jan P. A. M. Bogers, Dan Cohen, Peter F. J. Schulte
16 [GO] 2021―Jun―25 Drug-drug Interactions between COVID-19 Treatments and Antidepressants, Mood Stabilizers/Anticonvulsants, and Benzodiazepines: Integrated Evidence from 3 Databases Beatriz Oda Plasencia-García, María Isabel Rico-Rangel, Gonzalo Rodríguez-Menéndez, Ana Rubio-García, Jaime Torelló-Iserte, Benedicto Crespo-Facorro
17 [GO] 2020―Jun―25 Cross-Cultural Validity of Psychological Distress Measurement During the Coronavirus Pandemic Shuyan Liu, Andreas Heinz
 [1] 

17 Results       Page 1



[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.074 sec